KENNETH BATE Insider Trading
Get free email notifications about insider trading for KENNETH BATE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH BATE. KENNETH BATE is a EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and a ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and a Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and a Director in AVEO PHARMACEUTICALS INC ($AVEO) and a Director in Vanda Pharmaceuticals Inc. ($VNDA) and a Director in CATABASIS PHARMACEUTICALS INC ($CATB) and a Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and a Director in Epizyme, Inc. ($EPZM).
Address: MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE, 02139 MA
Companies in which KENNETH BATE is an Insider
AVEO PHARMACEUTICALS, INC.
Trading Symbol: AVEOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 30 2020
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOMARIN PHARMACEUTICAL INC
Trading Symbol: BMRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 11,875 shares
Current Value: $1,055,806
Latest Transaction: Jun 18 2015
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATABASIS PHARMACEUTICALS INC
Trading Symbol: CATBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 02 2021
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Trading Symbol: EPZMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 02 2020
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOCEA BIOSCIENCES, INC.
Trading Symbol: GNCAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MADRIGAL PHARMACEUTICALS, INC.
Trading Symbol: SNTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MILLENNIUM PHARMACEUTICALS INC
Trading Symbol: MLNMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: ExecVP; Head of Commercial Ops, EVP; Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Sep 27 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vanda Pharmaceuticals Inc.
Trading Symbol: VNDAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 5,000 shares
Current Value: $68,250
Latest Transaction: Jun 19 2017
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KENNETH BATE
Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 18 2020 | SNTA | MADRIGAL PHARMACEU ... | BATE KENNETH | Director | Option Exercise | A | 111.06 | 6,000 | 666,360 | 6,000 | |
Jun 12 2020 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
Jun 02 2020 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 |